Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 3/20 | 1.00 |
| ▸ | MAOB | P27338 | 2/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.55 |
| ▸ | MAPT | P10636 | 3/20 | 0.47 |
| ▸ | HTT | P42858 | 3/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.47 |
| ▸ | NPC1 | O15118 | 2/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.47 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.47 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.47 |
| ▸ | ADRA2B | P18089 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL670019 | 1.00 | MAOA (1.00) | MAOAMAOBALDH1A1MAPTHTT | |
| SCHEMBL2561898 | 0.98 | MAOA (0.96) | MAOAMAOBALDH1A1MAPTHTT | |
| SCHEMBL2561900 | 0.98 | MAOA (0.96) | MAOAMAOBALDH1A1MAPTHTT | |
| Benzene SCHEMBL10803509 | 0.91 | MAOA (0.82) | MAOAMAOBALDH1A1MAPTHTT | |
| SCHEMBL29785641 | 0.88 | MAOA (0.77) | MAOAMAOBALDH1A1MAPTHTT | |
| SCHEMBL2470956 | 0.88 | MAOA (0.77) | MAOAMAOBALDH1A1MAPTHTT | |
| SCHEMBL275526 | 0.88 | MAOA (0.77) | MAOAMAOBALDH1A1MAPTHTT | |
| SCHEMBL2557888 | 0.85 | MAOA (0.74) | MAOAMAOBALDH1A1MAPTHTT | |
| SCHEMBL4417764 | 0.84 | MAOA (0.71) | MAOAMAOBALDH1A1MAPTHTT | |
| SCHEMBL10596667 | 0.84 | MAOA (0.71) | MAOAMAOBALDH1A1MAPTHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 110 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113637047-A | Polypeptide-manganese-carbonyl compound CO release molecule with phenylazo pyridine as ligand and synthetic method and application thereof | 华南理工大学 | 2021-11-12 | — | — | CN | claimed |
| EP-2605774-B1 | MOLECULAR SWITCH | UNIV KIEL CHRISTIAN ALBRECHTS (DE) | 2018-11-14 | — | — | EP | claimed |
| US-9786420-B2 | Molecular switch | CHRISTIAN-ALBRECHTS-UNIVERSITÄT ZU KIEL (DE) | 2017-10-10 | — | — | US | claimed |
| US-9403864-B2 | Process for the synthesis of carbonucleoside and intermediates for use therein | ALPHORA RESEARCH INC. (CA) | 2016-08-02 | — | — | US | claimed |
| EP-2576556-B1 | PROCESS FOR THE SYNTHESIS OF CARBONUCLEOSIDE AND INTERMEDIATES FOR USE THEREIN | ALPHORA RES INC (CA) | 2015-08-26 | — | — | EP | claimed |
| US-20130202538-A1 | Molecular Switch | UNIVERSITATSKLINIKUM SCHLESWIG-HOLSTEIN (DE) | 2013-08-08 | — | — | US | claimed |
| EP-2605774-A1 | MOLECULAR SWITCH | Christian-Albrechts-Universität zu Kiel (DE) | 2013-06-26 | — | — | EP | claimed |
| US-20130144058-A1 | PROCESS FOR THE SYNTHESIS OF CARBONUCLEOSIDE AND INTERMEDIATES FOR USE THEREIN | ALPHORA RESEARCH INC. (CA) | 2013-06-06 | — | — | US | claimed |
| EP-2576556-A1 | PROCESS FOR THE SYNTHESIS OF CARBONUCLEOSIDE AND INTERMEDIATES FOR USE THEREIN | Alphora Research Inc. (CA) | 2013-04-10 | — | — | EP | claimed |
| WO-2012022299-A1 | MOLECULAR SWITCH | CHRISTIAN-ALBRECHTS-UNIVERSITÄT ZU KIEL (DE) | 2012-02-23 | — | — | WO | claimed |
| WO-2011150512-A1 | PROCESS FOR THE SYNTHESIS OF CARBONUCLEOSIDE AND INTERMEDIATES FOR USE THEREIN | ALPHORA RESEARCH INC. (CA) | 2011-12-08 | — | — | WO | claimed |
| US-6656867-B2 | Coordination catalyst | THE GOODYEAR TIRE & RUBBER COMPANY | 2003-12-02 | — | — | US | claimed |
| US-20030119662-A1 | Transition metal catalysts for diene polymerizations | THE GOODYEAR TIRE & RUBBER COMPANY | 2003-06-26 | — | — | US | claimed |
| US-6479601-B1 | Transition metal catalysts for diene polymerizations | THE GOODYEAR TIRE & RUBBER COMPANY | 2002-11-12 | — | — | US | claimed |
| US-20250100976-A1 | EXTERNAL STIMULUS-RESPONSIVE CLICK REACTION TECHNOLOGY | TOHOKU UNIVERSITY (JP) | 2025-03-27 | — | — | US | disclosed |
| EP-4424674-A1 | EXTERNAL STIMULUS-RESPONSIVE CLICK REACTION TECHNOLOGY | Tohoku University (JP) | 2024-09-04 | — | — | EP | disclosed |
| WO-2023073966-A1 | EXTERNAL STIMULUS-RESPONSIVE CLICK REACTION TECHNOLOGY | 国立大学法人東北大学 | 2023-05-04 | — | — | WO | disclosed |
| US-4204928-A | Photopolymerizable composition stabilized with nitrogen-containing aromatic compounds | STAUFFER CHEMICAL COMPANY (US) | 1980-05-27 | — | — | US | disclosed |
| US-4141807-A | ADDITION POLYMERS, QUINOLINE OR NAPHTHOL DERIVATIVES | STAUFFER CHEMICAL COMPANY (US) | 1979-02-27 | — | — | US | disclosed |
| US-3923774-A | Quinazolone containing phenyl-azo-pyridine compounds | BASF AG | 1975-12-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250100976-A1 | EXTERNAL STIMULUS-RESPONSIVE CLICK REACTION TECHNOLOGY | OXER1, ESR1, DNER | MAOA 2344/4885MAOB 2957/4885ALDH1A1 924/4885 |
| US-20130144058-A1 | PROCESS FOR THE SYNTHESIS OF CARBONUCLEOSIDE AND INTERMEDIATES FOR USE THEREIN | NUDT14, PGM2, PGD | MAOA 2954/4885MAOB 1108/4885ALDH1A1 2533/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.